NCT02857985

Brief Summary

The size of the infarct is particularly important prognostic marker. It is clearly established that the extent of the infarct is not only correlated to mortality, but also long-term adverse events. The evaluation of the infarct size at the acute phase of the disease is therefore an essential clinical tool to adapt the immediate treatment and follow-up of patients. It is therefore crucial to have techniques that are effective, precise, reproducible, and easily performed during the acute phase to quantify the size of the infarct following angioplasty. Myocardial scintigraphy and cardiac MRI have been the standard examinations for the evaluation of infarct size. However, these exams are difficult to perform during the acute phase of the infarct owing to difficulties in monitoring unstable patients and the limited availability of the apparatus. It is for this reason that the investigators would like to investigate the rotational angiography (RA), which is comparable to a scanner in its mode of action but does not require transfer of patients as performed using the same apparatus that used for diagnostic coronarography and therapeutic angioplasty. RA is a radiological technique that uses the system employed for coronagraph, and consists rotating the fixed C-Arm around the patient and acquisition of a series of images that are then reconstituted. The investigators propose to evaluate the size of the infarct using RA in comparison with cardiac MRI (standard examination) performed as soon as possible after RA and the investigators hope to demonstrated that RA allows the measurement of an infarct as precisely as cardiac MRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 7, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2013

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

August 3, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 5, 2016

Completed
Last Updated

January 29, 2018

Status Verified

January 1, 2018

Enrollment Period

6 months

First QC Date

August 3, 2016

Last Update Submit

January 26, 2018

Conditions

Keywords

Myocardial InfarctionMRIrotational angiography

Outcome Measures

Primary Outcomes (2)

  • infarct size measured by RA

    Day 1

  • infarct size measured by MRI

    Day 4

Study Arms (1)

Patient with Myocardial Infarction

EXPERIMENTAL
Device: 3D RADevice: MRI

Interventions

3D RADEVICE

3D RA is realised just after angioplasty.

Patient with Myocardial Infarction
MRIDEVICE

MRI is realised between 24h and 96h post angioplasty.

Patient with Myocardial Infarction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted for myocardial infarction and fulfilling the following criteria:
  • Transitory or persistent ST elevation
  • Coronary occlusion (TIMI 0) treated by angioplasty or thrombotic acute stenosis treated or not by angioplasty
  • Planned coronarography
  • With social security coverage
  • Not under any legal protection;
  • The consent form signed.

You may not qualify if:

  • Patient unconscious or confused;
  • Presenting:
  • cardiogenic shock;
  • or signs of cardiac insufficiency;
  • or sustained cardiac arrhythmia;
  • or atrial fibrillation;
  • or sustained extrasystole;
  • or high degree block;
  • Contraindication for MRI;
  • Known history of hypersensitivity to MRI contrast agent;
  • Risk of pregnancy or proven pregnancy based on interview data;
  • Breast feeding;
  • Patient subject to legal guardianship by a court;
  • Incapacity to express consent;
  • Patient not or badly understanding French.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Louis Pradel

Bron, 69500, France

Location

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2016

First Posted

August 5, 2016

Study Start

March 9, 2013

Primary Completion

September 7, 2013

Study Completion

September 7, 2013

Last Updated

January 29, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations